Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Intangibles: 2022

  • NewAmsterdam Pharma Co N.V's Intangibles was N/A to $81,629 in Q2 2023 from the same period last year, while for Jun 2023 it was $81,629, marking a year-over-year change of. This contributed to the annual value of $83,160 for FY2022, which is N/A change from last year.
  • NewAmsterdam Pharma Co N.V's Intangibles amounted to $81,629 in Q2 2023, which was down 1.84% from $83,160 recorded in Q4 2022.
  • In the past 5 years, NewAmsterdam Pharma Co N.V's Intangibles ranged from a high of $83,160 in Q4 2022 and a low of $81,629 during Q2 2023.
  • For the 2-year period, NewAmsterdam Pharma Co N.V's Intangibles averaged around $82,394, with its median value being $82,394 (2022).